Evidence map›Paper›PMID 39230994›Full record

ArticleInvestigative ophthalmology & visual science2024

Metabolic Phenotyping of Healthy and Diseased Human RPE Cells.

Saira Rizwan, Beverly Toothman, Bo Li, Abbi L Engel, Rayne R Lim, Sheldon Niernberger, Jinyu Lu, Cloe Ratliff, Yinxiao Xiang, Mark Eminhizer and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Selective deletion ofiScience · 2026
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Saira RizwanDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States.
Beverly ToothmanDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States.
Bo LiDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States.
Abbi L EngelDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Rayne R LimDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Sheldon NiernbergerDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Jinyu LuDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States.
Cloe RatliffDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States.
Yinxiao XiangDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States.
Mark EminhizerDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States.
Jennifer R ChaoDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Jianhai DuDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, West Virginia, United States.

Funding

WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI Travis Salisbury · 2012 to 2026
$61.1M
LABORATORY OF DEVELOPMENTAL BIOLOGYR24HD000836 · NICHD · UNIVERSITY OF WASHINGTON · PI Ian Amos Glass · 1995 to 2026
$16.9M
VS-CoBRE Administrative CoreP20GM144230 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Shian Liu · 2022 to 2026
$13.9M
Metabolic dysfunction from ECM remodeling in diseases of human RPER01EY034364 · NEI · UNIVERSITY OF WASHINGTON · PI Jennifer Rayming Chao, Jianhai Du · 2022 to 2026
$2.8M
Regulators of retinal metabolism in healthy and degenerating retinasR01EY031720 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ASH, JOHN D, DU, JIANHAI · 2020 to 2024
$2.4M
Retinal Mitochondrial Metabolism in Alzheimer's DiseaseR01EY031324 · NEI · WEST VIRGINIA UNIVERSITY · PI DU, JIANHAI · 2021 to 2024
$2.0M
Proline metabolism in retinal healthR01EY032462 · NEI · WEST VIRGINIA UNIVERSITY · PI DU, JIANHAI · 2021 to 2025
$1.9M
Metabolism of AMD iPSC-derived RPEU01EY034591 · NEI · UNIVERSITY OF WASHINGTON · PI CHAO, JENNIFER RAYMING, DU, JIANHAI · 2022 to 2024
$1.3M
NEI NIH HHS R01 EY031324NEI NIH HHS R01 EY031720NEI NIH HHS R01 EY032462NEI NIH HHS R01 EY034364NEI NIH HHS U01 EY034591NICHD NIH HHS R24 HD000836NIGMS NIH HHS P20 GM103434NIGMS NIH HHS P20 GM144230
6 · The paper itself

Abstract

Purpose: Metabolic defects in the retinal pigment epithelium (RPE) underlie many retinal degenerative diseases. This study aims to identify the nutrient requirements of healthy and diseased human RPE cells. Methods: We profiled nutrient use of various human RPE cells, including differentiated and dedifferentiated fetal RPE (fRPE), induced pluripotent stem cell-derived RPE (iPSC RPE), Sorsby fundus dystrophy (SFD) patient-derived iPSC RPE, CRISPR-corrected isogenic SFD (cSFD) iPSC RPE, and ARPE-19 cell lines using Biolog Phenotype MicroArray Assays. Results: Differentiated fRPE cells and healthy iPSC RPE cells can use 51 and 48 nutrients respectively, including sugars, intermediates from glycolysis and tricarboxylic acid (TCA) cycle, fatty acids, ketone bodies, amino acids, and dipeptides. However, when fRPE cells lose their epithelial phenotype through dedifferentiation, nutrient use becomes restricted to 17 nutrients, primarily sugar and glutamine-related amino acids. SFD RPE cells can use 37 nutrients; however, compared to cSFD RPE and healthy iPSC RPE, they are unable to use lactate, some TCA cycle intermediates, and short-chain fatty acids. Nonetheless, they show increased use of branch-chain amino acids (BCAAs) and BCAA-containing dipeptides. Dedifferentiated ARPE-19 cells grown in traditional culture media cannot use lactate and ketone bodies. In contrast, nicotinamide supplementation promotes differentiation toward an epithelial phenotype, restoring the ability to use these nutrients. Conclusions: Epithelial phenotype confers metabolic flexibility to healthy RPE for using various nutrients. SFD RPE cells have reduced metabolic flexibility, relying on the oxidation of BCAAs. Our findings highlight the potentially important roles of nutrient availability and use in RPE differentiation and diseases.

Indexed as

Cell DifferentiationInduced Pluripotent Stem CellsPhenotypeRetinal Pigment EpitheliumCell LineCells, CulturedHumans

Identifiers

PMID39230994
PMCPMC11379083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.